跳至主要内容
临床试验/CTRI/2023/03/050521
CTRI/2023/03/050521进行中(未招募)Unknown

Tapering vs standard dose of corticosteroids in severe alcohol-associated hepatitis –an open labelled randomized control trial.

AIG Hospitals0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
AIG Hospitals

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • WIth MELD score >21 and/or mDF >32
  • Patients with infection at baseline will be included if they have controlled infection.

排除标准

  • 1)Age < 18 years, > 70 years
  • 2)Active Infection
  • 3)Acute Kidney Injury (creatinine >1.5 mg/dl)
  • 4)Recent / ongoing bleed
  • 5)Active peptic ulcer disease
  • 6)Hepatocellular carcinoma, portal vein thrombosis or hepatic venous outflow tract obstruction
  • 7)Patients with concomitant other liver diseases including hepatitis B, C, NAFLD
  • 8)Patients with HIV
  • 9)Patients who are no willing to provide consent

研究者

发起方
AIG Hospitals

相似试验